1 |
Chung D (2000). Thymic carcinoma-analysis of nineteen clinicopathological studies. Thorac Cardiovasc Surg, 48, 114-119.
DOI
|
2 |
Detterbeck FC, Parsons AM (2011). Management of stage I and II thymoma. Thorac surg Clin, 21, 59-67.
DOI
|
3 |
Detterbeck FC, Zeeshan A (2013). Thymoma: current diagnosis and treatment. Chin Med J Engl, 126, 2186-91.
|
4 |
Engels EA, Pfeiffer RM (2003). Malignant thymoma in the United States demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer, 105, 546-51.
DOI
|
5 |
Kondo K, Monden Y (2003). Therapy for thymic epithelial tumors: a clinical study of 1320 patients from Japan. Ann Thorac Surg, 76, 878-84.
DOI
|
6 |
Lopez-Cano M, Ponseti-Bosch JM, Espin-Basany E, et al (2003). Clinical and pathologic predictors of outcome in Thymoma-Associated myasthenia gravis. Ann Thoracic Surgery, 76, 1643-9.
DOI
|
7 |
Usman A, Xiaopan Y, Frank D et al (2015). Thymic carcinoma outcomes and prognosis: Results of an international analysis. J Thorac Cardiovasc Surg, 149, 95-101.
DOI
|
8 |
Venuta F, Anile M, Diso D, et al (2010). Thymoma and thymic carcinoma. Eur J Cardiothorac Surg, 37, 13-25.
DOI
|
9 |
Weksler B, Dhupar R, Parikh V, et al (2013). Thymic carcinoma:a multivariate analysis of factors predictive of survival in 290 patients. Ann Thorac Surg, 95, 299-303.
DOI
|